Because the PI3-K/SGK1 pathway represents an alternative to ER-, PR- and Her2-mediated growth signaling, increased SGK1 expression could contribute to susceptibility to triple negative breast cancers [82]. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.